InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	INCANNEX HEALTHCARE LIMITED (IHL)
ISIN:	AU000000IHL8
Date of Listing:	23 May 2007
Date of Delisting:	29 November 2023
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 29 November 2023.

Legal Status: (updated monthly)

ACN: 096 635 246ABN: 93 096 635 246
Registration Date: 27 April 2001

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

INCANNEX HEALTHCARE LIMITED(IHL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
IMPRESSION HEALTHCARE LIMITED	31/10/2016	06/07/2020
MOUNT MAGNET SOUTH LIMITED	03/12/2015	31/10/2016
MOUNT MAGNET SOUTH NL		03/12/2015

Shareholder links

REGISTRY:

P.O. Box 43078 Providence, RI 02940-3078 United States of America

Tel :
Fax :
RegistryWebsite

Company details

ISIN: AU000000IHL8

Address: Level 23, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000
Tel: +61 (0) 422 180 317 Fax:

Date first listed: 23/05/2007
Company Secretary:
Sector: Health Care Equipment & Services Industry Group: XMJ
Activities: Pharmaceuticals

News & Events

Expand this box to read and print

delisted at entity's request under Listing Rule 17.11	29/11/2023
we understand under a scheme of arrangement Incannex Healthcare Inc. acquired all of the issued securities in IHL (at 1 new share or option for every 100 existing shares or options - except small parcel holders will eventually receive cash) effectively re-domiciling to the US and with shares listed on NASDAQ - Computershare US is the registry	29/11/2023
The securities of Incannex Healthcare Limited will be suspended from quotation at the close of trading on Friday, 17 November 2023 under Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with ASIC approving the scheme of arrangement by which Incannex Healthcare Inc. will acquire all of the issued securities in IHL.	17/11/2023
The suspension of trading in the securities of Incannex Healthcare Limited will be lifted immediately following the release by IHL of an announcement regarding a material update regarding IHL's psychedelic program.	15/03/2023
Interim analysis of study data to date indicates that there is a greater than 85% chance (>85%, alpha error probability 0.05) of the study showing a statistically significant benefit for the psilocybin treatment arm versus the placebo treatment arm at the conclusion of the study period. An independent Data Safety Monitoring Board (DSMB) has reviewed data from Incannex's ongoing Phase 2 "PsiGAD" clinical trial and recommends no changes to study design. The trial team and DSMB have identified no safety concerns to date.	15/03/2023
The securities of Incannex Healthcare Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IHL, pending the release of an announcement regarding a material update regarding IHL's psychedelic program.	14/03/2023
name changed from Impression Healthcare Limited	06/07/2020

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
31/10/2023	Peter Widdows	510,954	$0.066	$33,842.00
23/03/2018	Alistair Blake	35,000	$0.033	$1,140.00
04/12/2017	Kelvin Smith	90,000	$0.021	$1,879.00
02/06/2017	Alistair Blake	25,691	$0.041	$1,048.00
24/05/2017	Alistair Blake	34,466	$0.056	$1,916.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Troy Valentine	Non Exec Chairman	13/12/2017
Joel Latham	Managing Director, CEO	19/07/2018
Lekhram Changoer	CTO	28/06/2022
Peter Widdows	Non Exec Director	01/03/2018
Robert B. Clark	Director	17/08/2022
George Anastassov	Director	28/06/2022
Madhukar Bhalla	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.